Pharmacist Role in Thyroid Disorders

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

September 15, 2022

Study Completion Date

September 15, 2022

Conditions
HypothyroidismHyperthyroidismThyroid Diseases
Interventions
BEHAVIORAL

Clinical Pharmacist Intervention Group

Group to which the clinical pharmacist makes recommendations The drugs administered to patients during scheduled hospital visits will be recorded. A detailed medication review will be conducted by the clinical pharmacist. As a result of a comprehensive evaluation, recommendations were made to doctors regarding drug-related problems and were recorded.

Trial Locations (1)

34854

Marmara University, Istanbul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER

collaborator

Marmara University

OTHER

lead

Istanbul University - Cerrahpasa

OTHER